Part 1: Imaging findings of common immune checkpoint inhibitor-related adverse effects
Details
Publication Year 2022-06,Volume 66,Issue #4,Page 495-501
Journal Title
Journal of Medical Imaging and Radiation Oncology
Publication Type
Review
Abstract
Over the last decade or so, immunotherapy and in particular immune checkpoint inhibitors have become common in the treatment of numerous cancers and have revolutionised oncology. The unique mechanisms of these agents has resulted in novel tumour response patterns and also new drug-related toxicities, both of which can have specific findings on imaging. The widespread and increasing use of these agents means these findings are now encountered across many radiology practices beyond just specialist oncology units. This pictorial essay aims to describe and illustrate imaging findings associated with common and important immune-related adverse events as a result of treatment with immune checkpoint inhibitors.
Keywords
*Drug-Related Side Effects and Adverse Reactions; Humans; Immune Checkpoint Inhibitors; Immunotherapy/adverse effects; Medical Oncology; *Neoplasms/diagnostic imaging/drug therapy; autoimmunity; drug-related side effects and adverse reactions; immunotherapy
Department(s)
Cancer Imaging
PubMed ID
35244329
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2025-02-13 06:18:06
Last Modified: 2025-02-13 06:18:45

© 2025 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙